Dexamethasone in Orbital Cellulitis (DOC) Trial

Phase 4

• Conditions: Orbital cellulitis; Pre-septal cellulitis; Eye - Diseases / disorders of the eye

• Registration Number: ACTRN12622000808741
• Lead Sponsor: South Australian Institute of Ophthalmology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-06-08
• Last Update Posted: 15 May 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 128

Inclusion Criteria

Weight at least 5kg
Acute onset (within 14 days) of orbital cellulitis or severe pre-septal cellulitis secondary to any bacterial cause

Exclusion Criteria

Concomitant intracranial complications
Sepsis
Systemic immunosuppression
Suspected non-bacterial cause of orbital cellulitis, including fungal or tubercular infections
Treatment with systemic corticosteroids prior to admission
Dexamethasone allergy

Study & Design

• Study Type: Interventional
• Study Design: Not specified